vs
Anteris Technologies Global Corp.（AVR）与ESTABLISHMENT LABS HOLDINGS INC.（ESTA）财务数据对比。点击上方公司名可切换其他公司
ESTABLISHMENT LABS HOLDINGS INC.的季度营收约是Anteris Technologies Global Corp.的208.4倍（$64.6M vs $310.0K）。ESTABLISHMENT LABS HOLDINGS INC.自由现金流更多（$-2.0M vs $-18.9M）
Anteris Technologies Global Corp是一家专注于结构性心脏病诊疗解决方案的医疗科技企业，开发及商业化生物假体心脏瓣膜、经导管介入产品，服务北美、欧洲及亚太地区的医疗机构，核心业务覆盖心脏外科与介入心脏病学领域。
Establishment Labs Holdings Inc.是一家总部位于美国的无晶圆厂半导体企业，同时专注于人工智能领域业务，核心为数据中心及AI基础设施研发高速连接解决方案，于2024年3月在纳斯达克挂牌上市。
AVR vs ESTA — 直观对比
营收规模更大
ESTA
是对方的208.4倍
$310.0K
自由现金流更多
ESTA
多$16.9M
$-18.9M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $310.0K | $64.6M |
| 净利润 | $-29.2M | — |
| 毛利率 | 70.6% | 70.5% |
| 营业利润率 | -9343.5% | -6.1% |
| 净利率 | -9420.0% | — |
| 营收同比 | — | 45.2% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.74 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVRESTA
| Q4 25 | $310.0K | $64.6M | ||
| Q3 25 | $429.0K | $53.8M | ||
| Q2 25 | $618.0K | $51.3M | ||
| Q1 25 | $556.0K | $41.4M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | — | $40.2M | ||
| Q2 24 | — | $44.1M | ||
| Q1 24 | — | $37.2M |
净利润AVRESTA
| Q4 25 | $-29.2M | — | ||
| Q3 25 | $-22.2M | $-11.1M | ||
| Q2 25 | $-20.8M | $-16.6M | ||
| Q1 25 | $-21.9M | $-20.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-16.7M | ||
| Q2 24 | — | $-17.2M | ||
| Q1 24 | — | $-16.2M |
毛利率AVRESTA
| Q4 25 | 70.6% | 70.5% | ||
| Q3 25 | 71.3% | 70.1% | ||
| Q2 25 | 76.1% | 68.8% | ||
| Q1 25 | 62.8% | 67.2% | ||
| Q4 24 | — | 68.5% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 65.6% | ||
| Q1 24 | — | 65.6% |
营业利润率AVRESTA
| Q4 25 | -9343.5% | -6.1% | ||
| Q3 25 | -5190.0% | -7.5% | ||
| Q2 25 | -3379.3% | -27.5% | ||
| Q1 25 | -3917.3% | -41.0% | ||
| Q4 24 | — | -41.9% | ||
| Q3 24 | — | -32.7% | ||
| Q2 24 | — | -21.2% | ||
| Q1 24 | — | -23.8% |
净利率AVRESTA
| Q4 25 | -9420.0% | — | ||
| Q3 25 | -5185.1% | -20.7% | ||
| Q2 25 | -3371.2% | -32.3% | ||
| Q1 25 | -3932.4% | -50.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -41.5% | ||
| Q2 24 | — | -38.9% | ||
| Q1 24 | — | -43.6% |
每股收益（稀释后）AVRESTA
| Q4 25 | $-0.74 | $-0.07 | ||
| Q3 25 | $-0.62 | $-0.38 | ||
| Q2 25 | $-0.58 | $-0.57 | ||
| Q1 25 | $-0.61 | $-0.70 | ||
| Q4 24 | — | $-1.21 | ||
| Q3 24 | — | $-0.59 | ||
| Q2 24 | — | $-0.62 | ||
| Q1 24 | — | $-0.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $75.6M |
| 总债务越低越好 | $22.0K | — |
| 股东权益账面价值 | $-93.0K | $23.5M |
| 总资产 | $23.0M | $357.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVRESTA
| Q4 25 | — | $75.6M | ||
| Q3 25 | — | $70.6M | ||
| Q2 25 | — | $54.6M | ||
| Q1 25 | $49.0M | $69.2M | ||
| Q4 24 | — | $90.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务AVRESTA
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AVRESTA
| Q4 25 | $-93.0K | $23.5M | ||
| Q3 25 | $3.7M | $16.4M | ||
| Q2 25 | $24.4M | $22.8M | ||
| Q1 25 | $43.3M | $38.5M | ||
| Q4 24 | — | $53.1M | ||
| Q3 24 | — | $32.7M | ||
| Q2 24 | — | $45.0M | ||
| Q1 24 | — | $56.9M |
总资产AVRESTA
| Q4 25 | $23.0M | $357.2M | ||
| Q3 25 | $19.1M | $338.9M | ||
| Q2 25 | $39.9M | $329.7M | ||
| Q1 25 | $58.8M | $333.4M | ||
| Q4 24 | — | $346.8M | ||
| Q3 24 | — | $282.7M | ||
| Q2 24 | — | $285.1M | ||
| Q1 24 | — | $301.8M |
负债/权益比AVRESTA
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.5M | $-162.0K |
| 自由现金流经营现金流 - 资本支出 | $-18.9M | $-2.0M |
| 自由现金流率自由现金流/营收 | -6104.5% | -3.1% |
| 资本支出强度资本支出/营收 | 128.1% | 2.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-79.8M | $-56.9M |
8季度趋势，按日历期对齐
经营现金流AVRESTA
| Q4 25 | $-18.5M | $-162.0K | ||
| Q3 25 | $-18.3M | $-11.3M | ||
| Q2 25 | $-19.5M | $-18.8M | ||
| Q1 25 | $-21.5M | $-20.7M | ||
| Q4 24 | — | $-20.7M | ||
| Q3 24 | — | $-12.5M | ||
| Q2 24 | — | $-14.2M | ||
| Q1 24 | — | $-11.2M |
自由现金流AVRESTA
| Q4 25 | $-18.9M | $-2.0M | ||
| Q3 25 | $-19.0M | $-13.1M | ||
| Q2 25 | $-20.1M | $-20.4M | ||
| Q1 25 | $-21.7M | $-21.5M | ||
| Q4 24 | — | $-21.3M | ||
| Q3 24 | — | $-13.9M | ||
| Q2 24 | — | $-15.0M | ||
| Q1 24 | — | $-14.5M |
自由现金流率AVRESTA
| Q4 25 | -6104.5% | -3.1% | ||
| Q3 25 | -4434.5% | -24.4% | ||
| Q2 25 | -3247.9% | -39.7% | ||
| Q1 25 | -3909.5% | -51.9% | ||
| Q4 24 | — | -47.8% | ||
| Q3 24 | — | -34.6% | ||
| Q2 24 | — | -33.9% | ||
| Q1 24 | — | -38.9% |
资本支出强度AVRESTA
| Q4 25 | 128.1% | 2.8% | ||
| Q3 25 | 180.0% | 3.4% | ||
| Q2 25 | 86.9% | 3.2% | ||
| Q1 25 | 44.6% | 1.8% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 8.9% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
